NCT02941653

Brief Summary

Objectives: This study will determine the effectiveness of the use of desensitivity gels prior in office bleaching on risk and intensity of tooth sensitivity caused by in-office bleaching using 35% hydrogen peroxide. Materials and Methods: Fourty seven patients will be selected for this triple-blind, randomized, cross-over, placebo-controlled clinical trial. 10 minutes prior to bleaching procedure, patients will receive the the potassium nitrate 2% and potassium oxalate 5% desensitivity gel application on vestibular surface. The whitening treatment with 35% hydrogen peroxide will be carried out in two sessions with a 7-day interval. Tooth sensitivity will be assessed before, during and 24 hours after the procedure using analog visual and verbal scales. Color alteration will be assessed by a bleach guide scale and Vita Easy shade spectrophotometer 7 days after each session. Relative risk to sensitivity will be calculated and adjusted by session; while comparison of overall risk will performed by McNemar's test. Data on the sensitivity level for both scales and color shade will be subjected to the Friedman, Wilcoxon and Mann-Whitney tests, respectively (α = 0.05).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 21, 2016

Completed
11 days until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

April 11, 2018

Status Verified

April 1, 2018

Enrollment Period

8 months

First QC Date

October 19, 2016

Last Update Submit

April 9, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Risk to the tooth sensitivity

    The tooth sensitivity will be assessed using a Visual analogue (VAS) and verbal scales. VAS consisted of a 10-cm scale 0 (no sensitivity) 10 (unbearable sensitivity). A slightly air-stream will be applied over the buccal surfaces of the central incisors, and the patients will record their sensitivity perception by pointing with a pen on the scale. The distance between the marking and the border of scale, relative to the absence of sensitivity will be measured. The measurements will be scored according to the distance from 0, using a digital caliper. The tooth sensitivity will be evaluated using a 5-point Verbal rating scale (VRS), where 0 = none, 1 = mild, 2 = moderate, 3 = considerable and 4 = severe. Score different from 0 will determine presence of sensitivity. The risk of tooth sensitivity will be determined by relative risk assessed by ratio between absolute risk of experimental condition by those observed in control. The 95% confidence interval will be calculated.

    During the bleaching treatment.

Secondary Outcomes (4)

  • Level of tooth sensitivity

    During the Bleaching procedure

  • Risk after tooth sensitivity- after the procedure

    24 hours after the Bleaching procedure

  • Level of tooth sensitivity - after the procedure

    24 hours after the Bleaching procedure

  • Bleaching Effectiveness

    Before the bleaching procedures and 7 days after this

Study Arms (2)

Control: Potassium Nitrate 2% gel

ACTIVE COMPARATOR

The patient will receive the application of potassium nitrate 2% gel on vestibular surface teeth, for 10 minutes.

Device: Potassium nitrate 2% gel

Intervention: Potassium Oxalate 5% gel

EXPERIMENTAL

The patient will receive the application of potassium oxalate 5% gel on vestibular surface teeth, for 10 minutes.

Device: Potassium oxalate 5% gel

Interventions

* Teeth will be cleaned using rubber cups associated to pumice and water; * Relative isolation with roller cotton will be done; * Prior to each bleaching session, the patients will receive the potassium nitrate 2% desensitivity gel application on vestibular surface, for 10 minutes. * Gingival dam will be performed using a fluid resin (Top Dam, FGM, Brazil) * A 35% hydrogen peroxide based bleaching agent will be mixed and applied on the vestibular surface of teeth, remaining for 40 minutes.

Control: Potassium Nitrate 2% gel

* Teeth will be cleaned using rubber cups associated to pumice and water * Relative isolation with roller cotton will be done; * Prior to each bleaching session, the patients will receive the potassium OXALATE 5% * Gingival dam will be performed using a fluid resin (Top Dam, FGM, Brazil) desensitivity gel application on vestibular surface, for 10 minutes. * A 35% hydrogen peroxide based bleaching agent will be mixed and applied on the vestibular surface of teeth, remaining for 40 minutes.

Intervention: Potassium Oxalate 5% gel

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients included in this clinical trial will be at least 18 years old with good oral health;
  • Patients presenting all six upper anterior teeth with shade mismatching with 2.5 M2 (Vita Bleachguide 3D-Master scale, Vita-Zahnfabrik, Bad Sackingen, Germany) or darker will be included.

You may not qualify if:

  • Patients with any of the six upper anterior teeth with caries;
  • Restorations in anterior teeth'
  • Patients with tooth severe discoloration (e.g., stains caused by tetracycline);
  • Presence of enamel hypoplasia;
  • Presence of gingival recession or dentin exposure;
  • Presence of tooth pulpitis or endodontics;
  • Participants submitted to previous bleaching procedures;
  • Patients with prior tooth sensitivity;
  • Patients with known allergy to any component of medication used in the study;
  • Pregnant or breastfeeding will also be also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Flavia Pardo Salata Nahsan

Aracaju, Sergipe, 49060-100, Brazil

Location

Study Officials

  • Flavia Pardo S Nahsan, PhD

    Universidade Federal de Sergipe

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 19, 2016

First Posted

October 21, 2016

Study Start

November 1, 2016

Primary Completion

July 1, 2017

Study Completion

October 1, 2017

Last Updated

April 11, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations